Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy

Research highlights Biomarkers that would predict response to neoadjuvant chemotherapy in advanced ovarian cancer patients are eagerly needed: • Neutrophil to Lymphocyte Ratio (NLR) is an indicator of systemic inflammatory response to the malignancy. • NLR was evaluated in 132 patients undergoing Ne...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	M. Liontos, A. Andrikopoulou, K. Koutsoukos, C. Markellos, E. Skafida, O. Fiste, M. Kaparelou, N. Thomakos, D. Haidopoulos, A. Rodolakis, M. A. Dimopoulos, F. Zagouri
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	Gynecology and obstetrics RG1-991
Acceso en línea:	https://doaj.org/article/b86ff7d8ecf44fa4ad5387a7df88a008
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b86ff7d8ecf44fa4ad5387a7df88a008
record_format	dspace
spelling	oai:doaj.org-article:b86ff7d8ecf44fa4ad5387a7df88a0082021-11-08T11:03:58ZNeutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy10.1186/s13048-021-00902-01757-2215https://doaj.org/article/b86ff7d8ecf44fa4ad5387a7df88a0082021-11-01T00:00:00Zhttps://doi.org/10.1186/s13048-021-00902-0https://doaj.org/toc/1757-2215Research highlights Biomarkers that would predict response to neoadjuvant chemotherapy in advanced ovarian cancer patients are eagerly needed: • Neutrophil to Lymphocyte Ratio (NLR) is an indicator of systemic inflammatory response to the malignancy. • NLR was evaluated in 132 patients undergoing Neoadjuvant Chemotherapy for advanced ovarian cancer. • Elevated NLR was associated with worse prognosis. • No association between NLR and response to chemotherapy was noted.M. LiontosA. AndrikopoulouK. KoutsoukosC. MarkellosE. SkafidaO. FisteM. KaparelouN. ThomakosD. HaidopoulosA. RodolakisM. A. DimopoulosF. ZagouriBMCarticleGynecology and obstetricsRG1-991ENJournal of Ovarian Research, Vol 14, Iss 1, Pp 1-10 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Gynecology and obstetrics RG1-991
spellingShingle	Gynecology and obstetrics RG1-991 M. Liontos A. Andrikopoulou K. Koutsoukos C. Markellos E. Skafida O. Fiste M. Kaparelou N. Thomakos D. Haidopoulos A. Rodolakis M. A. Dimopoulos F. Zagouri Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
description	Research highlights Biomarkers that would predict response to neoadjuvant chemotherapy in advanced ovarian cancer patients are eagerly needed: • Neutrophil to Lymphocyte Ratio (NLR) is an indicator of systemic inflammatory response to the malignancy. • NLR was evaluated in 132 patients undergoing Neoadjuvant Chemotherapy for advanced ovarian cancer. • Elevated NLR was associated with worse prognosis. • No association between NLR and response to chemotherapy was noted.
format	article
author	M. Liontos A. Andrikopoulou K. Koutsoukos C. Markellos E. Skafida O. Fiste M. Kaparelou N. Thomakos D. Haidopoulos A. Rodolakis M. A. Dimopoulos F. Zagouri
author_facet	M. Liontos A. Andrikopoulou K. Koutsoukos C. Markellos E. Skafida O. Fiste M. Kaparelou N. Thomakos D. Haidopoulos A. Rodolakis M. A. Dimopoulos F. Zagouri
author_sort	M. Liontos
title	Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
title_short	Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
title_full	Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
title_fullStr	Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
title_full_unstemmed	Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
title_sort	neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
publisher	BMC
publishDate	2021
url	https://doaj.org/article/b86ff7d8ecf44fa4ad5387a7df88a008
work_keys_str_mv	AT mliontos neutrophiltolymphocyteratioandchemotherapyresponsescoreasprognosticmarkersinovariancancerpatientstreatedwithneoadjuvantchemotherapy AT aandrikopoulou neutrophiltolymphocyteratioandchemotherapyresponsescoreasprognosticmarkersinovariancancerpatientstreatedwithneoadjuvantchemotherapy AT kkoutsoukos neutrophiltolymphocyteratioandchemotherapyresponsescoreasprognosticmarkersinovariancancerpatientstreatedwithneoadjuvantchemotherapy AT cmarkellos neutrophiltolymphocyteratioandchemotherapyresponsescoreasprognosticmarkersinovariancancerpatientstreatedwithneoadjuvantchemotherapy AT eskafida neutrophiltolymphocyteratioandchemotherapyresponsescoreasprognosticmarkersinovariancancerpatientstreatedwithneoadjuvantchemotherapy AT ofiste neutrophiltolymphocyteratioandchemotherapyresponsescoreasprognosticmarkersinovariancancerpatientstreatedwithneoadjuvantchemotherapy AT mkaparelou neutrophiltolymphocyteratioandchemotherapyresponsescoreasprognosticmarkersinovariancancerpatientstreatedwithneoadjuvantchemotherapy AT nthomakos neutrophiltolymphocyteratioandchemotherapyresponsescoreasprognosticmarkersinovariancancerpatientstreatedwithneoadjuvantchemotherapy AT dhaidopoulos neutrophiltolymphocyteratioandchemotherapyresponsescoreasprognosticmarkersinovariancancerpatientstreatedwithneoadjuvantchemotherapy AT arodolakis neutrophiltolymphocyteratioandchemotherapyresponsescoreasprognosticmarkersinovariancancerpatientstreatedwithneoadjuvantchemotherapy AT madimopoulos neutrophiltolymphocyteratioandchemotherapyresponsescoreasprognosticmarkersinovariancancerpatientstreatedwithneoadjuvantchemotherapy AT fzagouri neutrophiltolymphocyteratioandchemotherapyresponsescoreasprognosticmarkersinovariancancerpatientstreatedwithneoadjuvantchemotherapy
_version_	1718442463275778048

Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy

Ejemplares similares